IN8bio (INAB) announced updated data from the ongoing Phase 1 trial of INB-100, an allogeneic, haploidentical gamma-delta T cell therapy in older patients with hematologic malignancies undergoing ...

After hours: December 13 at 5:24:57 PM EST Loading Chart for INAB ...